Based on the Polarean Imaging Plc stock forecast from 0 analysts, the average analyst target price for Polarean Imaging Plc is not available over the next 12 months. Polarean Imaging Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Polarean Imaging Plc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Polarean Imaging Plc’s stock price was GBX 3.90. Polarean Imaging Plc’s stock price has changed by +0.00% over the past week, -11.36% over the past month and -84.08% over the last year.
No recent analyst target price found for Polarean Imaging Plc
No recent average analyst rating found for Polarean Imaging Plc
Company Overview Polarean Imaging Plc
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. Its research equipment includes HPX hyperpolarizer, HPX measurement station, HPX gas manifold, chest coil, and dose delivery bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina. Read Less
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It...Read More
Frequently Asked Questions About Polarean Imaging Plc (POLX:LSE) Stock
Stock Target Advisor's fundamental analysis for Polarean Imaging Plc's stock is Very Bearish.
Unfortunately we do not have enough data on POLX:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on POLX:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on POLX:LSE's stock to indicate if its overvalued.
The last closing price of POLX:LSE's stock was GBX 3.90.
The most recent market capitalization for POLX:LSE is GBX 8.43M.
Unfortunately we do not have enough analyst data on POLX:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Polarean Imaging Plc's stock.
As per our most recent records Polarean Imaging Plc has 28 Employees.
Polarean Imaging Plc's registered address is 2500 Meridian Pkwy, Durham, NC, United States, 27713.
You can get more information about it from Polarean Imaging Plc's website at https://polarean.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for POLX:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
